BioPharma Credit (LSE:BPCR) Stock Based Compensation : $0.0 Mil (TTM As of Dec. 2022)

View and export this data going back to 2017. Start your Free Trial

What is BioPharma Credit Stock Based Compensation?

BioPharma Credit's Stock Based Compensation for the six months ended in Dec. 2022 was $0.0 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2022 was $0.0 Mil.

BioPharma Credit Stock Based Compensation Historical Data

The historical data trend for BioPharma Credit's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioPharma Credit Stock Based Compensation Chart

BioPharma Credit Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Stock Based Compensation

Get a 7-Day Free Trial

BioPharma Credit Semi-Annual Data
	Jun17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Dec23
Stock Based Compensation	Get a 7-Day Free Trial							-	-	-	-	-

BioPharma Credit Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2022 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.0 Mil.

BioPharma Credit Stock Based Compensation Related Terms

Thank you for viewing the detailed overview of BioPharma Credit's Stock Based Compensation provided by GuruFocus.com. Please click on the following links to see related term pages.

BioPharma Credit Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » BioPharma Credit PLC (LSE:BPCR) » Definitions » Stock Based Compensation

Comparable Companies

Traded in Other Exchanges

N/A

Address

65 Gresham Street, 6th Floor, London, GBR, EC2V 7NQ

Website

https://www.bpcruk.com

BioPharma Credit PLC is an investment company. The investment objective of the company is to generate long-term shareholder returns predominantly in the form of sustainable income distributions from exposure to the life sciences industry. The only reporting segment of the company is the investment in debt assets secured by royalties or other cash flows derived from the sale of approved life sciences products. The company generates revenue in the form of interest income, income from subsidiaries, royalty revenue, make-whole and prepayment income, dividends, and paydown fees. The company earns a majority of its revenue from Investment income.

BioPharma Credit Headlines

No Headlines